Eurofins CDMO Alphora News and Resources

Radyus Research and Eurofins CDMO Alphora have announced a strategic partnership aimed at streamlining early-stage drug development for biotech clients globally. The collaboration brings together Radyus’s development and regulatory expertise with Alphora’s process development and GMP manufacturing capabilities. Based in the U.S., Radyus

Eurofins CDMO Alphora has announced plans to build a new biologics manufacturing facility in Mississauga, Ontario. The 50,000 sq ft GMP facility will produce monoclonal antibodies (mAbs) and protein therapies for clinical and commercial use. This development is part of